Literature DB >> 3632685

Isolation and characterization of the alpha and beta chains of human platelet glycoprotein Ib.

V A Canfield, J Ozols, D Nugent, G J Roth.   

Abstract

Human platelet glycoprotein Ib has been purified in milligram amounts from platelets obtained by pheresis of thrombocytotic donors. Purification steps included lectin (wheat germ agglutinin) and immuno (murine monoclonal anti-glycoprotein Ib antibody)-affinity chromatography. The disulfide-linked individual alpha and beta chains of GPIb were separated and the amino-terminal amino acid sequence of each chain was determined. Rabbit polyclonal antibody directed against each individual chain was prepared by affinity chromatography and shown to be monospecific by western blot analysis using whole platelet lysate as antigen. These studies outline a useful approach to isolate and characterize the individual chains of GPIb.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3632685     DOI: 10.1016/0006-291x(87)90963-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence.

Authors:  J A Lopez; D W Chung; K Fujikawa; F S Hagen; E W Davie; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

2.  The collagen-binding integrin α2β1 is a novel interaction partner of the Trimeresurus flavoviridis venom protein flavocetin-A.

Authors:  Franziska T Arlinghaus; Johannes A Eble
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

3.  Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D I Simon; Z Chen; H Xu; C Q Li; J f Dong; L V McIntire; C M Ballantyne; L Zhang; M I Furman; M C Berndt; J A López
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.